Erratum: Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography: The Silent Diabetes Study (Diabetologia (2011) 54 (2968) (DOI 10.1007/s00125-011-2253-y));Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study

Diabetologia

Volumn 54, Issue 11, 2011, Pages 2923-2930

  Doerr, R ^a   Hoffmann, U ^a   Otter, W ^b   Heinemann, L ^c   Hunger Battefeld, W ^d   Kulzer, B ^e   Klinge, A ^f   Lodwig, V ^g   Amann Zalan, I ^g   Sturm, D ^h   Tschoepe, D ⁱ   Spitzer, S G ^a   Stumpf, J ^a   Lohmann, T ^j   Schnell, O ^k  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b ZIM Center for Internal Medicine   (Germany)

^c Profil   (Germany)

^d University Clinics   (Germany)

^e Diabetes Center   (Germany)

^f Diabetes Practice   (Germany)

^g ROCHE DIAGNOSTICS GMBH   (Germany)

^h General Practice   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j Dresden Neustadt Hospital   (Germany)

^k INSTITUTE OF EPIDEMIOLOGY   (Germany)

more..

Author keywords

Coronary angiography; Coronary artery disease; Diabetes; Oral glucose tolerance testing

Indexed keywords

HEMOGLOBIN A1C;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 80054701699     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2298-y     Document Type: Erratum

References (37)

1. I Kowalska J Prokop H Bachorzewska-Gajewska, et al. 2001 Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis Diabetes Care 24 897 901 11347751 10.2337/diacare.24.5.897 1:CAS:528:DC%2BD3MXjvVCku7k%3D (Pubitemid 33636066)
2. A Norhammar A Tenerz G Nilsson, et al. 2002 Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2140 2144 12090978 10.1016/S0140- 6736(02)09089-X 1:CAS:528:DC%2BD38XkslGhsb8%3D (Pubitemid 34694020)
3. JJ Meier S Deifuss B Gallwitz A Klamann W Schmiegel MA Nauck 2002 Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction Dtsch Med Wochenschr 127 1123 1129 12085306 10.1055/s-2002-31529 1:CAS:528:DC%2BD38XkvVOhsro%3D (Pubitemid 34620505)
4. M Bartnik L Ryden R Ferrari, et al. 2004 The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart Eur Heart J 25 1880 1890 15522466 10.1016/j.ehj.2004.07.027 1:CAS:528:DC%2BD2cXptFOgt7k%3D (Pubitemid 39452604)
5. M Bartnik K Malmberg A Norhammar A Tenerz J Ohrvik L Ryden 2004 Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction Eur Heart J 25 1990 1997 15541834 10.1016/j.ehj.2004.09.021 1:CAS:528:DC%2BD2cXpslWnurg%3D (Pubitemid 39486017)
6. D-Y Hu CY Pan JM Yu 2006 The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey Eur Heart J 27 2573 2579 16984927 10.1093/eurheartj/ehl207 1:CAS:528:DC%2BD28XhtlanurnE (Pubitemid 44627302)
7. T Schondorf G Luebben E Karagiannis E Erdmann T Forst A Pfuetzner 2010 Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study Diab Vasc Dis Res 7 145 150 20382778 10.1177/1479164109358241
8. AD Deshpande M Harris-Hayes M Schootman 2008 Epidemiology of diabetes and diabetes-related complications Phys Ther 88 1254 1264 18801858 10.2522/ptj.20080020
9. S Yusuf S Hawken S Ounpuu, et al. 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937 952 15364185 10.1016/S0140-6736(04)17018-9 (Pubitemid 39208455)
10. M Lenzen L Ryden J Ohrvik, et al. 2006 Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart Eur Heart J 27 2969 2974 17090612 10.1093/eurheartj/ ehl363 (Pubitemid 44950440)
11. M Bartnik L Ryden K Malmberg, et al. 2007 Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart Heart 93 72 77 16905628 10.1136/hrt.2005.086975 1:STN:280: DC%2BD28jjtFKmsQ%3D%3D (Pubitemid 46094058)
12. The International Expert Committee 2009 International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 1327 1334 10.2337/dc09-9033
13. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. WHO Department of Noncommunicable Disease Surveillance, Geneva
14. American Diabetes Association 2004 Standards of medical care in diabetes Diabetes Care 27 suppl 1 S15 S34
15. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
16. GG Gensini C Buonanno 1968 Coronary arteriography. A study of 100 cases with angiographically proved coronary artery disease Dis Chest 54 90 99 5665309 10.1378/chest.54.2.90 1:STN:280:DyaF1czls1egtw%3D%3D
17. D Youden 1950 Index for rating diagnostic tests Cancer 3 32 5 15405679 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 1:STN:280:DyaG3c%2FhsFeisw%3D%3D
18. V Mohan V Vijayachandrika K Gokulakrishnan, et al. 2010 A1C cut points to define various glucose intolerance groups in Asian Indians Diabetes Care 33 515 519 19903752 10.2337/dc09-1694 1:CAS:528:DC%2BC3cXkvValsbg%3D
19. 1c) in screening for undiagnosed diabetes in the US population Diabetes Care 23 187 191 10868829 10.2337/diacare.23.2.187 1:STN:280: DC%2BD3cvntFOrsQ%3D%3D (Pubitemid 30071022)
20. S Colagiuri Z Hussain P Zimmet A Cameron J Shaw 2004 Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience Diabetes Care 27 367 371 14747215 10.2337/diacare.27.2.367 (Pubitemid 38174059)
21. C Buell D Kermah MB Davidson 2007 Utility of A1C for diabetes screening in the 1999-2004 NHANES population Diabetes Care 30 2233 2235 17563338 10.2337/dc07-0585 1:CAS:528:DC%2BD2sXhtV2mu7rM (Pubitemid 47359021)
22. DL Christensen DR Witte L Kaduka, et al. 2010 Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups Diabetes Care 33 580 582 20009099 10.2337/dc09-1843 1:CAS:528: DC%2BC3cXkvValtrw%3D
23. ZX Lu KZ Walker K ODea KA Sikaris JE Shaw 2010 A1C for screening and diagnosis of type 2 diabetes in routine clinical practice Diabetes Care 33 817 819 20067965 10.2337/dc09-1763
24. W Otter S Kleybrink W Doering E Standl O Schnell 2004 Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus Diabet Med 21 183 187 14984455 10.1111/j.1464-5491.2004.01114.x 1:STN:280:DC%2BD2c%2FpsFarsQ%3D%3D (Pubitemid 38221819)
25. M Coutinho HC Gerstein Y Wang S Yusuf 1999 The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 233 240 10333939 10.2337/diacare.22.2.233 1:STN:280: DyaK1M3ms1Crsw%3D%3D (Pubitemid 29056916)
26. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 234 9673301 10.1056/NEJM199807233390404 1:STN:280:DyaK1czivVKgsg%3D%3D (Pubitemid 28350165)
27. M Ishihara S Kojima T Sakamoto, et al. 2005 Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era Am Heart J 150 814 820 16209987 10.1016/j.ahj.2004.12. 020 1:CAS:528:DC%2BD2MXhtVymsL%2FF (Pubitemid 41396520)
28. O Schnell E Standl 2006 Impaired glucose tolerance, diabetes, and cardiovascular disease Endocr Pract 12 Suppl 1 16 19 16627374 (Pubitemid 44963605)
29. The DECODE study group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe Lancet 354 617 621 10.1016/S0140-6736(98)12131-1 (Pubitemid 29391424)
30. F Ning J Tuomilehto K Pyorala A Onat S Soderberg Q Qiao 2010 Cardiovascular disease mortality in Europeans in relation to fasting and 2 h plasma glucose levels within a normoglycemic range Diabetes Care 33 2211 2216 20424221 10.2337/dc09-2328
31. J Tuomilehto J Lindstrom JG Eriksson, et al. 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 1343 1350 11333990 10.1056/NEJM200105033441801 1:STN:280:DC%2BD3M3kvFejsA%3D%3D (Pubitemid 32378388)
32. WC Knowler E Barrett-Connor SE Fowler, et al. 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 393 403 11832527 10.1056/NEJMoa012512 1:CAS:528:DC%2BD38XhtVWqurc%3D (Pubitemid 34437694)
33. O Schnell O Schafer S Kleybrink W Doering E Standl W Otter 2004 Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry Diabetes Care 27 455 460 14747228 10.2337/diacare.27.2.455 (Pubitemid 38174071)
34. O Schnell W Otter E Standl 2009 The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice Diabetes Care 32 suppl 2 S326 S330 19875574 10.2337/dc09-S332
35. L Ryden E Standl M Bartnik, et al. 2007 Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 88 136 17220161 10.1093/eurheartj/ehm124 1:CAS:528:DC%2BD2sXitlaiur8%3D (Pubitemid 47355991)
36. PW Serruys MC Morice AP Kappetein, et al. 2009 Percutaneous coronary intervention vs coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 961 972 19228612 10.1056/NEJMoa0804626 1:CAS:528:DC%2BD1MXislOlsLo%3D
37. AP Banning S Westaby MC Morice, et al. 2010 Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease. Comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 1067 1075 20079596 10.1016/j.jacc.2009.09.057 1:CAS:528:DC%2BC3cXkvVeitbY%3D